Abattis Bioceuticals Corp.

OTCPK:ATTB.F Stock Report

Market Cap: US$476.0

Abattis Bioceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Rob Abenante

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.6yrs
CEO ownershipn/a
Management average tenure6.5yrs
Board average tenure6.1yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Rob Abenante (41 yo)

7.6yrs

Tenure

CA$375,648

Compensation

Mr. Robert J. Abenante, BBA, MPAcc, CA, has been Chief Executive Officer and President of International Iconic Gold Exploration Corp. (formerly known as Marifil Mines Limited) since November 07, 2017 and s...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Abenante
President7.6yrsCA$375.65kno data
Francesco Paolini
CFO & Director5.6yrsno datano data
Patrick Mitchell
COO & Director6yrsno datano data
Shawn Balaghi
Head of Corporate Development6.5yrsno datano data
Jim Carter
Head of Mergers and Acquisitions Advisory6.5yrsno datano data
Christopher Cherry
Corporate Comptroller8.2yrsno datano data
Nicole Breitinger
Corporate Secretary6.2yrsno datano data

6.5yrs

Average Tenure

Experienced Management: ATTB.F's management team is seasoned and experienced (6.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert Abenante
President7.5yrsCA$375.65kno data
Francesco Paolini
CFO & Director5.6yrsno datano data
Patrick Mitchell
COO & Director5.1yrsno datano data
Brazos Arthur Minshew
Head of the Medical Advisory Board6.5yrsno datano data
Cedric Wilson
Director6.1yrsno datano data

6.1yrs

Average Tenure

Experienced Board: ATTB.F's board of directors are considered experienced (6.1 years average tenure).